Calidi Biotherapeutics Financial Overview
Calidi Biotherapeutics's market cap is currently $10.46M. The company's EPS TTM is $-2.21; its P/E ratio is -0.17; Calidi Biotherapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
